13th Annual Rush Alzheimer’s Disease Center Meeting
Dr. Goodenowe presents at the 13th Annual Rush Alzheimer’s Disease Center ROSMAP Investigator’s Meeting 2022 at the Rush University Medical Center in Chicago, IL. Dr.
July 11, 2022
Welcome to Prodrome
Our products are scientifically designed for medical professionals. You must register for an account to place an order
If you are a medical professional please register for an account to order our products to carry in your office or to get your medical access code that can be used by your patients to purchase directly from us.
If you are not a medical professional please use the access code provided by your doctor to register for an account to access our store.
Thank you for your interest in Prodrome!
Already registered? Login to order now.
“A paradigm-altering view of Alzheimer’s.”
Dale Bredesen, MD
Author of The New York Times Bestseller The End of Alzheimer’s
“Dayan Goodenowe has drilled down to the very core of what makes us tick. His patient 25 year journey of research and invention has unpacked unique and marvelous understanding into how our metabolic engine works. We have a whole new field of medicine opening up called “metabolic medicine” and it runs right through Dr. Goodenowe’s inventions. Like tuning your carburetor and timing your engine, we can now heal your mitochondria and make your peroxisomes whistle with the careful measurement and replacement of plasmalogens. The implications of his inventions can’t be overstated. This is the end of Alzheimer’s, Parkinson’s, cancer….and who knows what lies ahead in the paradigm shift to true wellness with the absence of disease.”
John E. Whitcomb, MD
Brookfield Longevity Medical Clinic
“A brilliant and ground-breaking text on the science and clinical application of plasmalogens for the therapeutic amelioration of Alzheimer’s Dementia. I have had the good fortune of observing firsthand the significant, clinical benefits in my patients with neurodegenerative disorders for whom I’ve prescribed plasmalogen therapy.”
Mitchel Fleisher, M.D., D.Ht., D.A.B.F.M., Dc.A.B.C.T.
Medical Director, Center for Integrative & Regenerative Medicine
“Dr. Goodenowe has not only identified a biomarker—plasmalogen—that is strongly correlated with dementia, but he has also discovered a way to track and improve that marker allowing ApoE4 carriers, at the highest genetic risk for Alzheimer’s, to potentially avoid disease onset. Indeed, many of our members have had a noticeable improvement after addressing low levels.”
Julie Gregory
Founder & President of ApoE4.Info
“A bold and promising approach. Dr. Goodenowe has performed groundbreaking and compelling research which is detailed in the book so that afflicted patients and health professionals will become aware of a discovery which may very well change our approach to Alzheimer’s. We have been deploying plasmalogen precursors at the Regenesis Project and have found that within the timeframe of a few weeks, people become more alert and cognizant.”
Sheldon Jordan, MD, FAAN, DABPN, DABCN
Medical Director, the Regenesis Project
“I strongly recommend this book which I hope will be as transformative for you as it has been for me. It is easy to read and understand and will impact your everyday decision making.”
Plasmalogen Supplement Product Comparison*
Prodrome plasmalogen supplements contain 100-900x more plasmalogen than other plasmalogen supplement brands available!
PRICE (MONTH)
PLASMALOGENS (MG) PER BOTTLE
SERVING DOSE
PRICE PER MG
SOURCE
NUMBER OF BOTTLES EQUAL TO ONE PRODROME BOTTLE
$199.00
27,000 mg
900 mg
$0.0073 / mg
Vegan
1 bottle
$84.95
60 mg
2 mg
$1.42 / mg
Scallop
450 bottles
$96.00
30 mg
1 mg
$3.20 / mg
Marine animal
900 bottles
$88.90
30 mg
1 mg
$2.90 / mg
Scallop
900 bottles
$99.00
240 mg
8 mg
$0.41 / mg
Marine animal
112.5 bottles
*Comparisons are from product information advertised on e-commerce websites on July 14, 2021. Prodrome is not affiliated with the products listed above in any way.
ProdromeScan Blood Test
A revolution in health optimization.
Based on Dr. Dayan Goodenowe’s invention in 1999 and over 15 years of clinical research. Measures hundreds of molecules and key biochemical systems critical for optimal health and longevity.
Dietary Supplements
Our supplements are scientifically designed to correct deficiencies in key molecules identified by our ProdromeScan blood test.
ProdromeNeuro and ProdromeGlia Plasmalogen Supplements
Plasmalogen molecules are necessary for optimal health and longevity. The research evidence is now overwhelming, with hundreds of physicians using our plasmalogen supplements with their patients. ProdromeNeuro Plasmalogen Oil is funded by the Alzheimer’s Association (PCTR-16-381605, Part the CloudTM ).
ProdromeGTA
ProdromeGTA is specifically formulated to mimic activity that compensates for a gastrointestinal tract acid (GTA) deficiency. This deficiency is identified by our ProdromeScan blood test. GTAs are molecules that originate in the gut. Low levels are linked to an increased risk of colorectal cancer and pancreatic cancer.
ProdromeNeuro Alzheimer’s Clinical Trial Published
The results from our clinical trial with Dr. Sheldon Jordan are now published in a peer reviewed journal here. ProdromeNeuroTM plasmalogen supplement successfully improved cognition
July 6, 2022
Dr. Goodenowe presents at the Reverse Alzheimer’s Summit
Join Dr. Goodenowe at the Reverse Alzheimer’s Summit! Hear about the latest advancements in science, medicine, technology, and more to show you how to reverse Alzheimer’s
June 17, 2022
ProdromeGlia now available in soft gels
We are delighted to announce that we are now offering ProdromeGlia in soft gels!This is a different format than our previous capsules, and while Prodrome
May 3, 2022
Dr. Goodenowe presents at ISEAI Conference May 22, 2022
Dr. Dayan Goodenowe is proud to present at the 3rd annual The International Society for Environmentally Acquired Illness (ISEAI) Conference. This will be a virtual,
May 3, 2022
Dr. Goodenowe presents at Senescence Summit April 22-23
Dr. Dayan Goodenowe is pleased to present at the upcoming Senescence Summit. Senescence is the hallmark of aging. It’s a pro-inflammatory response that spreads diseased
April 17, 2022
Dayan Goodenowe, PhD
Founder and CEO
Inventor. Biochemist. Neuroscientist. Synthetic organic chemist. International speaker. Entrepreneur.
Dr. Goodenowe invented an advanced mass spectrometry technology platform in 1999 that has been used to analyze thousands of human samples from around the world and continues to be the most advanced technology of its kind today. Using this technology, he established collaborations with world-renowned international researchers and physicians in dementia, Alzheimer’s, Parkinson’s, multiple sclerosis, colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, bipolar disorder, schizophrenia, and several other diseases. Dr. Goodenowe is an expert on the biochemical basis of disease. His passion is targeted optimization of human biochemistry for longevity and vitality.
20 Years of Research
Dr. Goodenowe’s Technology Platform:
- Invented in 1999
- Over 50 scientific publications
- 19 patents
- Over 25 diseases studied
- Over 30 academic collaborations worldwide
- Tens of thousands of human blood and tissue samples analyzed
Learn more at www.DrGoodenowe.com
To learn more about the science behind the Prodrome products, visit Dr. Goodenowe's educational website where he shares his vast knowledge, expertise, and research.
Learn more at www.DrGoodenowe.com
To learn more about the science behind the Prodrome products, visit Dr. Goodenowe's educational website where he shares his vast knowledge, expertise, and research.
Sales
NEWS
13th Annual Rush Alzheimer’s Disease Center Meeting
July 11, 2022
Dr. Goodenowe presents at the 13th Annual Rush Alzheimer’s Disease Center ROSMAP Investigator’s Meeting 2022 at the Rush University Medical Center in Chicago, IL. Dr.
ProdromeNeuro Alzheimer’s Clinical Trial Published
July 6, 2022
The results from our clinical trial with Dr. Sheldon Jordan are now published in a peer reviewed journal here. ProdromeNeuroTM plasmalogen supplement successfully improved cognition
Dr. Goodenowe presents at the Reverse Alzheimer’s Summit
June 17, 2022
Join Dr. Goodenowe at the Reverse Alzheimer’s Summit! Hear about the latest advancements in science, medicine, technology, and more to show you how to reverse Alzheimer’s
ProdromeGlia now available in soft gels
May 3, 2022
We are delighted to announce that we are now offering ProdromeGlia in soft gels!This is a different format than our previous capsules, and while Prodrome
Dr. Goodenowe presents at ISEAI Conference May 22, 2022
May 3, 2022
Dr. Dayan Goodenowe is proud to present at the 3rd annual The International Society for Environmentally Acquired Illness (ISEAI) Conference. This will be a virtual,
Dr. Goodenowe presents at Senescence Summit April 22-23
April 17, 2022
Dr. Dayan Goodenowe is pleased to present at the upcoming Senescence Summit. Senescence is the hallmark of aging. It’s a pro-inflammatory response that spreads diseased
CONTACT US
40880 County Center Drive, Suite R, Temecula, CA 92591, USA
Call us
+001 951 296-3130
Get in touch
info@prodromesciences.com